← FDA Drug Approvals (Drugs@FDA)

METRONIDAZOLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: COSETTE · Approved 2023-07-12

Drug application

FDA Application #

ANDA216323

Application type

Abbreviated New Drug Application (Generic)

Brand name

METRONIDAZOLE

Generic name

METRONIDAZOLE

Active ingredients

METRONIDAZOLE

Dosage form

GEL

Route

VAGINAL

Marketing status

Prescription

Sponsor

COSETTE

Manufacturer

Cosette Pharmaceuticals, Inc.

First approval

2023-07-12

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown